{"title":"[Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice].","authors":"K Hanke, S P F Blum","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>BACKGROUND, OUTCOME AND METHODS: Observational study of the clinical efficacy and tolerance of the cefpodoxime proxetil preparation, Podomexef. The study was conducted from August 1996 to April 1997. A total of 549 practitioners participated, 2,734 patients were recruited, and the data of 2714 patients were analyzed.</p><p><strong>Dosage: </strong>Podomexef 200 film tablets, 2x daily.</p><p><strong>Indication: </strong>Bacterial infections of the upper and lower airways and ENT infections.</p><p><strong>Results: </strong>Global clinical efficacy was assessed by the physicians to be \"very good\" and \"good\" in 96.4% of the cases. With regard to tolerance, the physicians' assessment was \"very good\" and \"good\" in 96.3%. In 51 patients (1.9%), 70 adverse drug reactions involving the gastrointestinal tract, CNS and skin occurred.</p><p><strong>Conclusion: </strong>Under day-to-day doctor's office conditions, Podomexef 200 film tablets are both effective and well tolerated in the treatment of bacterial infections of the airways and ENT infections.</p>","PeriodicalId":12358,"journal":{"name":"Fortschritte der Medizin. Originalien","volume":"120 1","pages":"21-8"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fortschritte der Medizin. Originalien","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND, OUTCOME AND METHODS: Observational study of the clinical efficacy and tolerance of the cefpodoxime proxetil preparation, Podomexef. The study was conducted from August 1996 to April 1997. A total of 549 practitioners participated, 2,734 patients were recruited, and the data of 2714 patients were analyzed.
Dosage: Podomexef 200 film tablets, 2x daily.
Indication: Bacterial infections of the upper and lower airways and ENT infections.
Results: Global clinical efficacy was assessed by the physicians to be "very good" and "good" in 96.4% of the cases. With regard to tolerance, the physicians' assessment was "very good" and "good" in 96.3%. In 51 patients (1.9%), 70 adverse drug reactions involving the gastrointestinal tract, CNS and skin occurred.
Conclusion: Under day-to-day doctor's office conditions, Podomexef 200 film tablets are both effective and well tolerated in the treatment of bacterial infections of the airways and ENT infections.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
